FDA Approves Supplement for Fluorescite by Alcon Labs
The FDA has approved a supplemental application for Fluorescite, which contains fluorescein sodium.
Therapeutic Area
Therapeutic area intelligence for Diagnostic Agent with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.